Evicenter
Qulipta (atogepant) in Preventive treatment of migraine
Manufacturer
AbbVie Inc.
Prescribing information
Qulipta (opens in a new tab)
Questions
71
Last updated

All questions

Clinical trials: Qulipta (atogepant) in preventive treatment of migraine

13 questions · 5 sources

Study results

How much does Qulipta reduce monthly migraine days in episodic migraine (ADVANCE)?

Applies to Preventive treatment of episodic migraine in adults

Note: The HCP page cites the Prescribing Information (its reference 1) for these results; the Prescribing Information reports the trial as Study 1 (NCT03777059), with the same group sizes and baselines. The design passage describes the two episodic migraine studies together.

Did every Qulipta dose reduce episodic migraine days vs placebo?

Applies to Preventive treatment of episodic migraine in adults

Note: Table columns are QULIPTA 10 mg, QULIPTA 30 mg, QULIPTA 60 mg, and placebo, in that order; each row lists its values in that order.

How much does Qulipta reduce monthly migraine days in chronic migraine (PROGRESS)?

Applies to Preventive treatment of chronic migraine in adults

Note: The HCP page cites the Prescribing Information (its reference 1) for these results; the Prescribing Information reports the trial as Study 3 (NCT03855137). Table 5 columns are QULIPTA 60 mg and placebo, in that order; each row lists its values in that order.

What share of Qulipta episodic migraine patients had 50% fewer migraine days (ADVANCE)?

Applies to Preventive treatment of episodic migraine in adults

Note: The HCP page cites the Prescribing Information (its reference 1) for these results; the Prescribing Information reports the trial as Study 1; the last two passages are from its Table 3. Table columns are QULIPTA 10 mg, QULIPTA 30 mg, QULIPTA 60 mg, and placebo, in that order; each row lists its values in that order.

How many chronic migraine patients had 50% fewer migraine days on Qulipta?

Applies to Preventive treatment of chronic migraine in adults

Note: Table 5 columns are QULIPTA 60 mg and placebo, in that order; each row lists its values in that order.

How many episodic migraine patients had no migraine days on Qulipta (ADVANCE)?

Applies to Preventive treatment of episodic migraine in adults

Note: The page labels this an additional endpoint and reports it for the ADVANCE episodic migraine trial; a 100% reduction in monthly migraine days means no migraine days across the 12 weeks. The page cites AbbVie data on file (its reference 4) for these figures; the Prescribing Information does not report this endpoint.

Does Qulipta reduce acute medication use days in episodic migraine?

Applies to Preventive treatment of episodic migraine in adults

Note: Table columns are QULIPTA 10 mg, QULIPTA 30 mg, QULIPTA 60 mg, and placebo, in that order; each row lists its values in that order.

Does Qulipta reduce acute medication use days in chronic migraine?

Applies to Preventive treatment of chronic migraine in adults

Note: Table 5 columns are QULIPTA 60 mg and placebo, in that order; each row lists its values in that order.

Does Qulipta improve daily activities in episodic migraine (ADVANCE)?

Applies to Preventive treatment of episodic migraine in adults

Note: The HCP page cites the Prescribing Information (its reference 1) for these results; the Prescribing Information reports the trial as Study 1; the last three passages are from its Table 3. Table columns are QULIPTA 10 mg, QULIPTA 30 mg, QULIPTA 60 mg, and placebo, in that order; each row lists its values in that order.

Does Qulipta improve daily activities in chronic migraine (AIM-D PDA)?

Applies to Preventive treatment of chronic migraine in adults

Note: Table 5 columns are QULIPTA 60 mg and placebo, in that order; each row lists its values in that order.

Was Qulipta studied in chronic migraine with medication overuse headache?

Applies to Preventive treatment of chronic migraine in adults

Note: Both passages describe the chronic migraine trial (Study 3 in the label, PROGRESS on the HCP page). The HCP page cites AbbVie data on file (its reference 6) for the medication overuse figure.

Comparative studies

Qulipta vs topiramate: how did side effects compare (TEMPLE)?

Note: Table columns are QULIPTA 60 mg once daily (N=273) and topiramate (N=267), in that order. The HCP page cites AbbVie data on file for these results.

Qulipta vs topiramate: how did weight change (TEMPLE)?

Note: In the table, the first value in each row is for QULIPTA 60 mg and the second for topiramate. The table's * and † marks are defined in the last passage; the ‡, §, and ¶ marks of the first passage are defined in the passage before it.